Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Pfizer”
- A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia AreataActive Not Recruiting
Sponsor: Pfizer
Severe Alopecia Areata
United States, China, Czechia, France, Italy +4 more
- ATTR-CM: A Multi-country, Non-interventional Disease RegistryActive Not Recruiting
Sponsor: Pfizer
Transthyretin Amyloid Cardiopathy
Hong Kong, Malaysia, Taiwan
- A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental VitiligoActive Not Recruiting
Sponsor: Pfizer
Vitiligo
United States, Australia, Bulgaria, Canada, China +8 more
Sponsor: Astellas Pharma Global Development, Inc.
Muscle-invasive Bladder Cancer
United States, Germany, Japan, South Korea, Spain +1 more
- A Study to Learn How Effective is PCV20 to Help Stop Adults Who Have a Higher Chance of Getting PneumoniaActive Not Recruiting
Sponsor: Pfizer
Community-Acquired Pneumonia (CAP)
United States
- Study of Pregnancy Outcomes in Women Exposed to Rimegepant During PregnancyActive Not Recruiting
Sponsor: Pfizer
Migraine
United States
Sponsor: Pfizer
Dermatomyositis · Polymyositis
United States, Argentina, Bulgaria, China, Hungary +7 more
- A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489Active Not Recruiting
Sponsor: Pfizer
Pulmonary Hypertension
United States, Australia, Belgium, China, Czechia +5 more
Sponsor: Pfizer
COVID-19 Infection
United States, Argentina, Belgium, Brazil, Denmark +13 more
Sponsor: Pfizer
Colitis, Ulcerative
United States, Australia, Canada, France, Germany +5 more
Sponsor: Pfizer
Multiple Myeloma
United States, Argentina, Australia, Austria, Belgium +21 more
- A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative ColitisActive Not Recruiting
Sponsor: Pfizer
Colitis, Ulcerative
Canada, Germany, United Kingdom
- Impact of Using a GLP1 on Treatment Related Side Effects of Lung Cancer Patients Receiving LorlatinibNot Yet Recruiting
Sponsor: University of Chicago
Lung Cancer
United States
Sponsor: Pfizer
Multiple Myeloma
United States, Australia, Austria, Belgium, Brazil +19 more
Sponsor: Pfizer
Cachexia · Metastatic Pancreatic Ductal Adenocarcinoma
United States, Australia, Belgium, Brazil, Bulgaria +16 more
Sponsor: Pfizer
Metastatic Castration Resistant Prostate Cancer (mCRPC) · Small Cell Lung Cancer (SCLC) · Follicular Lymphoma (FL)
United States, Bulgaria, China, Japan, Poland +3 more
- A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe EczemaNot Yet Recruiting
Sponsor: Pfizer
Atopic Dermatitis
United States
Sponsor: Pfizer
Metastatic Castration-Resistant Prostate Cancer
United States, Argentina, Brazil, Bulgaria, Canada +22 more
Sponsor: Pfizer
Healthy
United States, Argentina, Brazil, Canada, Finland +9 more
Sponsor: Pfizer
Multiple Myeloma
United States, Argentina, Australia, Belgium, Brazil +22 more
Sponsor: Pfizer
Acute Treatment of Migraine
United States, Israel
- A Study to Learn About the Study Medicine Called Rimegepant in Adults When Used for the Prevention of Chronic MigraineNot Yet Recruiting
Sponsor: Pfizer
Preventive Treatment of Migraine
United States
Sponsor: Pfizer
Healthy
Belgium
Sponsor: Pfizer
Migraine
United States, Canada, France, Italy, Japan +2 more
- A Study to Learn About the Outcomes Between Study Medicines, Enzalutamide and Darolutamide Among Men With Metastatic Castration Sensitive Prostate Cancer (mCSPC)Not Yet Recruiting
Sponsor: Pfizer
Metastatic Castration Sensitive Prostate Cancer (mCSPC)